EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence-enabled clinical decision support: device regulation and decision influence

Huzaifa S Wasanwala, Jacob T Kannarkat iD, David W Bates

Journal of the American Medical Informatics Association · 16.11.2026

DOI: 10.1093/jamia/ocag155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, online erschienen am 16.11.2026. Verfasst von Huzaifa S Wasanwala und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, United States. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Artificial intelligence (AI)-enabled clinical decision support (CDS) challenges core assumptions of the Food and Drug Administration’s (FDA) recently updated CDS guidance, including the concepts of independent clinician review of outputs and manufacturer-intended use for exempting certain CDS tools from medical device regulation. Materials and Methods We examine the FDA’s January 2026 CDS guidance in the context of the evolving landscape of AI-enabled CDS tools, clinician interaction studies with AI-enabled CDS, and AI governance frameworks.

Results

Although the FDA’s framework distinguishes non-device CDS from regulated software, AI-enabled CDS may synthesize and transform clinical information in ways that are difficult to verify during routine care, increasing clinician susceptibility to automation bias.

Discussion

Incorporating pragmatic triggers into existing governance frameworks can help identify scenarios with a heightened risk for clinical decision influence.

Conclusion

Oversight calibrated to real-world clinical decision influence is needed to strengthen practical safety standards for AI-enabled CDS.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligenceclinical decision supportelectronic health recordsgovernancepolicy

Autor:innen und Institutionen

  • Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, United States.
  • Department of Psychiatry, Yale School of Medicine, New Haven, CT 06511, United States.
  • Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, United States.
  • Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.

ORCID-Profile: Jacob T Kannarkat

Zitieren

APA

Wasanwala, H. S., Kannarkat, J. T., & Bates, D. W. (2026). Artificial intelligence-enabled clinical decision support: device regulation and decision influence. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocag155

Vancouver

Wasanwala HS, Kannarkat JT, Bates DW. Artificial intelligence-enabled clinical decision support: device regulation and decision influence. Journal of the American Medical Informatics Association. 2026. doi:10.1093/jamia/ocag155

BibTeX
@article{Wasanwala2026,
  author = {Wasanwala, Huzaifa S and Kannarkat, Jacob T and Bates, David W},
  title = {Artificial intelligence-enabled clinical decision support: device regulation and decision influence},
  journal = {Journal of the American Medical Informatics Association},
  year = {2026},
  doi = {10.1093/jamia/ocag155}
}
Kostenlos starten →